Form 4: Arteris Inc. CFO Nicholas Hawkins Sells 11,000 Shares
SEC Form 4 Filing
Nicholas Hawkins, CFO of Arteris, Inc., sold 11,000 shares of common stock at an average price of $10.3292 on February 3, 2025, according to a Form 4 filing.
Summary
- On February 3, 2025, Nicholas B. Hawkins, the VP and Chief Financial Officer of Arteris, Inc., sold 11,000 shares of the company's common stock.
- The sale was executed at a weighted average price of $10.3292 per share.
- The transactions occurred at prices ranging from $10.06 to $10.44.
- Following the transaction, Hawkins directly owns 154,308 shares of Arteris, Inc.
- The sale was conducted under a pre-arranged 10b5-1 trading plan adopted on May 20, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although this sale was conducted under a pre-arranged trading plan.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. They can be part of a pre-planned diversification strategy or for personal financial planning. The use of a 10b5-1 trading plan helps to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation and stock ownership are typical components of corporate governance.
- Comparing Hawkins' stock ownership and trading activity to those of CFOs at similar semiconductor IP companies (e.g., ARM, Imagination Technologies, Synopsys, Cadence) would provide context.
- Analyzing the prevalence and terms of 10b5-1 trading plans among peer companies would also be relevant.
Stakeholder Impact
- The stock sale could have a minor impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates concerns about insider trading.
- The sale does not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2024-05-20 | Date the Reporting Person adopted the 10b5-1 trading plan |
| 2025-02-03 | Date of the stock sale transaction |
| 2025-02-05 | Date of the Form 4 filing |
Keywords
Arteris, Nicholas Hawkins, CFO, stock sale, Form 4, 10b5-1 trading plan, executive compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.